ASPIRIN AND OTHER ANTIPLATELET AGENTS IN THE SECONDARY AND PRIMARY PREVENTION OF CARDIOVASCULAR-DISEASE

被引：227

作者：

HENNEKENS, CH

BURING, JE

SANDERCOCK, P

COLLINS, R

PETO, R

机构：

[1] HARVARD UNIV,SCH MED,DEPT MED,CHANNING LAB,BOSTON,MA 02115

[2] HARVARD UNIV,SCH MED,DEPT PREVENT MED,BOSTON,MA 02115

[3] BRIGHAM & WOMENS HOSP,BOSTON,MA 02115

[4] UNIV EDINBURGH,DEPT NEUROL,EDINBURGH EH8 9YL,MIDLOTHIAN,SCOTLAND

[5] UNIV OXFORD,RADCLIFFE INFIRM,CLIN TRIAL SERV UNIT,OXFORD OX2 6HE,ENGLAND

来源：

CIRCULATION | 1989年 / 80卷 / 04期

关键词：

D O I：

10.1161/01.CIR.80.4.749

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：749 / 756

页数：8

共 67 条

[1]

ACHESON J, 1988, British Medical Journal, V296, P320

[2] CONTROLLED TRIAL OF DIPYRIDAMOLE IN CEREBRAL VASCULAR DISEASE [J].

ACHESON, J ;

DANTA, G ;

HUTCHINSON, EC .

BMJ-BRITISH MEDICAL JOURNAL, 1969, 1 (5644) :614-+

[3]

[Anonymous], 1980, FDA Drug Bull, V10, P2

[4]

[Anonymous], 1985, FDA Drug Bull, V15, P34

[5]

BARNETT HJM, 1978, NEW ENGL J MED, V299, P53

[6]

Belanger C, 1989, NEW ENGL J MED, V321, P129

[7]

BELANGER C, 1988, NEW ENGL J MED, V318, P262

[8]

BENOWITZ NL, 1988, NEW ENGL J MED, V319, P1318

[9]

BLAKELY J A, 1979, Thrombosis and Haemostasis, V42, P161

[10] AICLA CONTROLLED TRIAL OF ASPIRIN AND DIPYRIDAMOLE IN THE SECONDARY PREVENTION OF ATHERO-THROMBOTIC CEREBRAL-ISCHEMIA [J].

BOUSSER, MG ;

ESCHWEGE, E ;

HAGUENAU, M ;

LEFAUCCONNIER, JM ;

THIBULT, N ;

TOUBOUL, D ;

TOUBOUL, PJ .

STROKE, 1983, 14 (01) :5-14

← 1 2 3 4 5 6 7 →